Norris Financial Group, LLC
- SEC CIK
- 0002129318
- Latest filing
- Aug 5, 2026
CRSP holding history
CRISPR Therapeutics AG in every 13F filed by Norris Financial Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRSP overviewAll 13F holders of CRSPFull Q2 2026 holdings
- Shares (Q2 2026)
- 9,061
- Value
- $494.2K
- % of portfolio
- 0.2%
- Quarters held
- 14
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 9,061 | $494.2K | 0.2% | +1,804+24.9% | Added | Holders |
| Q1 2026 | 7,257 | $345.2K | 0.1% | −585−7.5% | Reduced | Holders |
| Q4 2025 | 7,842 | $411.2K | 0.1% | −112−1.4% | Reduced | Holders |
| Q3 2025 | 7,954 | $515.5K | 0.2% | −1,771−18.2% | Reduced | Holders |
| Q2 2025 | 9,725 | $473.0K | 0.2% | +48+0.5% | Added | Holders |
| Q1 2025 | 9,677 | $329.3K | 0.2% | +3,113+47.4% | Added | Holders |
| Q4 2024 | 6,564 | $258.4K | 0.1% | −3,790−36.6% | Reduced | Holders |
| Q3 2024 | 10,354 | $486.4K | 0.2% | +240+2.4% | Added | Holders |
| Q2 2024 | 10,114 | $546.3K | 0.3% | −2,445−19.5% | Reduced | Holders |
| Q1 2024 | 12,559 | $856.0K | 0.5% | −2,308−15.5% | Reduced | Holders |
| Q4 2023 | 14,867 | $930.7K | 0.6% | +417+2.9% | Added | Holders |
| Q3 2023 | 14,450 | $655.9K | 0.5% | +2,356+19.5% | Added | Holders |
| Q2 2023 | 12,094 | $679.0K | 0.5% | +12,094 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −3,502−100.0% | Sold out | Holders |
| Q1 2022 | 3,502 | $219.8K | 0.1% | +3,502 | New | Holders |